A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 1U01CA218259-01A1
Quantitative High Throughput Screening for Small Molecules Targeting CD47 in Cancer
National Cancer Institute
Grant: 1ZIATR000053-03
Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery
National Cancer Institute
Grant: ZIASC009172
Avon Foundation for Women
Grant: 02-2015-045
Avon Foundation for Women
Grant: 02-2014-051
Avon Foundation for Women
Grant: 02-2015-095
Avon Foundation for Women
Grant: 02-2017-034
NCI NIH HHS
Grant: U01 CA218259
Intramural NIH HHS
Grant: ZIA TR000053
National Institutes of Health
Grant: 1ZIASC009172-07
Cellular Interactions with Thrombospondin
FWCI
1.22
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals